Answer
Ciprofloxacin, a CYP1A2 inhibitor, increased rasagiline mesilate exposure (AUC) by 83% when co-administered; potent CYP1A2 inhibitors should therefore be administered with caution.
Sources for this answer
- Azilect 1 mg TabletsTeva Pharmaceuticals Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 13Document updated
Sources checked